comparemela.com

Latest Breaking News On - Adjuvant chemotherapy - Page 2 : comparemela.com

Uncertainty Surrounds Sensitivity of ctDNA in CRC

ctDNA is a useful prognostic tool in CRC, but it's unclear whether it can guide the use of adjuvant chemotherapy.

United statesMemorial sloan kettering cancer centerNew yorkDavid ellisonAparna raj parikhHiroki yukamiEujung kimHarvard medical schoolPeter maccallum cancer centrePashtoon murtaza kasiWeill cornell medicineJeannie tieRaj parikhNot sensitiveColorectal cancerColorectal cancer crc

Study Validates Breast Recurrence Score Across Ethnic Groups

A recent study validated the predictive biomarker's effectiveness in guiding treatment decisions for diverse groups.

United statesUniversity of illinoisHsiao ching huangUniversity of illinois college pharmacyJournal of the national comprehensive cancer networkPacific islanderHispanic blackHispanic whiteIllinois collegeNational comprehensive cancerBreast cancerAlignant breast neoplasmBreast carcinomaHer2 negative breast cancerHer2 breast cancerMammary gland

Presence of ctDNA Does Not Predict Benefit of Adjuvant Chemotherapy in Stage II Colon Cancer

Adjuvant chemotherapy did not improve circulating tumor DNA clearance in patients with stage II colon cancer with baseline circulating tumor DNA.

United statesVank morrisDepartment of gastrointestinal medical oncologyUniversity of texas md anderson cancer centerGastrointestinal medical oncologyCancer centerAdjuvant chemotherapyPatients with low riskTage ii colon cancerNrg gi005 cobra trialGastrointestinal cancers symposium asco giThe university of texas md anderson cancer center

Gastric Cancer Survival Differs by Race and Ethnicity

Overall, Asian and Hispanic patients demonstrated better survival than White and Black patients.

United statesRoger williams medical centerRhode islandSteve kwonBoston universityNational cancer databaseNoncolorectal gastrointestinal cancerOncolorectal gi cancerGastric cancerAlignant stomach neoplasmStomach cancerGastric carcinomaAlignant neoplasiaAlignant neoplasmAdjuvant chemotherapyLymph nodes

No Added Benefit From Chemo in This Breast Cancer Subtype

Adding chemotherapy to endocrine therapy for women with ER-positive, HER2-negative invasive lobular carcinoma does not improve survival outcomes.

Bernadetteam heemskerk gerritsenErasmus medical center cancer instituteErasmus medical centerNetherlands cancerBreast cancerAlignant breast neoplasmBreast carcinomaLobular cancerLobular carcinomaAlignant neoplasiaAlignant neoplasmAdjuvant chemotherapyMammary glandEndocrine therapyGenomics genomic medicineEpidermal growth factor receptor

vimarsana © 2020. All Rights Reserved.